R. Vaillancourt

1.3k total citations
42 papers, 1.1k citations indexed

About

R. Vaillancourt is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, R. Vaillancourt has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 7 papers in Pharmacology. Recurrent topics in R. Vaillancourt's work include Antiplatelet Therapy and Cardiovascular Diseases (8 papers), Eicosanoids and Hypertension Pharmacology (7 papers) and Nuclear physics research studies (7 papers). R. Vaillancourt is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (8 papers), Eicosanoids and Hypertension Pharmacology (7 papers) and Nuclear physics research studies (7 papers). R. Vaillancourt collaborates with scholars based in United States, Canada and Romania. R. Vaillancourt's co-authors include Daniel Deykin, Joseph A. Jakubowski, Gary L. Johnson, Craig B. Thompson, C. R. Valeri, Anne M. Gardner, J.A. Jakubowski, John W. Daly, Kenneth B. Seamon and Michael W. Edwards and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

R. Vaillancourt

40 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Vaillancourt United States	17	331	204	197	172	126	42	1.1k
Markus Jerling Sweden	20	283 0.9×	235 1.2×	267 1.4×	94 0.5×	56 0.4×	44	1.3k
G. Sponer United States	18	216 0.7×	81 0.4×	490 2.5×	78 0.5×	89 0.7×	63	1.0k
C J Bowmer United Kingdom	19	339 1.0×	177 0.9×	84 0.4×	82 0.5×	117 0.9×	68	1.1k
Sam Rebello United States	21	215 0.6×	129 0.6×	357 1.8×	60 0.3×	256 2.0×	58	1.1k
K. Strein Germany	15	185 0.6×	238 1.2×	355 1.8×	88 0.5×	67 0.5×	58	988
J. D. Tange Australia	24	376 1.1×	192 0.9×	94 0.5×	337 2.0×	136 1.1×	77	1.9k
J. Eileen Bird United States	21	305 0.9×	160 0.8×	229 1.2×	59 0.3×	164 1.3×	38	1.0k
Sarah R. Bujac United Kingdom	15	248 0.7×	127 0.6×	150 0.8×	67 0.4×	187 1.5×	18	930
I. Pham France	20	191 0.6×	135 0.7×	450 2.3×	325 1.9×	169 1.3×	37	1.2k
Jan Jaap van Lier United States	18	318 1.0×	123 0.6×	162 0.8×	64 0.4×	74 0.6×	38	1.0k

Countries citing papers authored by R. Vaillancourt

Since Specialization

Citations

This map shows the geographic impact of R. Vaillancourt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Vaillancourt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Vaillancourt more than expected).

Fields of papers citing papers by R. Vaillancourt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Vaillancourt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Vaillancourt. The network helps show where R. Vaillancourt may publish in the future.

Co-authorship network of co-authors of R. Vaillancourt

This figure shows the co-authorship network connecting the top 25 collaborators of R. Vaillancourt. A scholar is included among the top collaborators of R. Vaillancourt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Vaillancourt. R. Vaillancourt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Labbé, Catherine, Michaela R. Anderson, Serge Simard, et al.. (2017). Wait Times for Diagnosis and Treatment of Lung Cancer: A Single-Centre Experience. Current Oncology. 24(6). 367–373. 21 indexed citations

2.

Labbé, Catherine, et al.. (2016). Wait times for diagnosis and treatment of lung cancer: a single centre experience. Annals of Oncology. 27. vi523–vi523. 4 indexed citations

3.

Doucet, Mariève, Denis R. Joanisse, Richard Debigaré, et al.. (2010). Atrophy and hypertrophy signalling of the quadriceps and diaphragm in COPD. Thorax. 65(11). 963–970. 36 indexed citations

4.

O’Connor, Kyle P., Franck Molin, Paul Poirier, & R. Vaillancourt. (2008). Cardiac arrest as a major complication of bilateral cervico-dorsal sympathectomy. Interactive Cardiovascular and Thoracic Surgery. 8(2). 238–239. 13 indexed citations

5.

Hoying, James B., et al.. (2007). Increased hexokinase II expression in the renal glomerulus of mice in response to arsenic. Toxicology and Applied Pharmacology. 224(1). 39–48. 11 indexed citations

6.

Vaillancourt, R.. (2006). Le temps de l’incertitude. Presses de l'Université du Québec eBooks. 2 indexed citations

7.

Vaillancourt, R.. (2006). Le temps de l’incertitude. Presses de l'Université du Québec eBooks. 3 indexed citations

8.

Doucet, Mariève, Richard Debigaré, Denis R. Joanisse, et al.. (2004). Adaptation of the diaphragm and the vastus lateralis in mild-to-moderate COPD. European Respiratory Journal. 24(6). 971–979. 59 indexed citations

9.

Brown, Michael L., et al.. (1992). Elevated glucose alters A23187-induced release of arachidonic acid from porcine aortic endothelial cells by enhancing reacylation. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1165(2). 239–247. 7 indexed citations

10.

Jakubowski, Joseph A., R. Vaillancourt, & Daniel Deykin. (1988). Interaction of ethanol, prostacyclin, and aspirin in determining human platelet reactivity in vitro.. Arteriosclerosis An Official Journal of the American Heart Association Inc. 8(4). 436–441. 47 indexed citations

11.

Rocklin, Ross E., et al.. (1988). Altered arachidonic acid metabolism and platelet size in atopic subjects. Clinical Immunology and Immunopathology. 46(3). 352–359. 21 indexed citations

12.

Vaillancourt, R., et al.. (1985). Modulation of forskolin binding to rat brain membranes.. PubMed. 10(6). 535–49. 15 indexed citations

13.

Jakubowski, Joseph A., Craig B. Thompson, R. Vaillancourt, C. R. Valeri, & Daniel Deykin. (1983). Arachidonic acid metabolism by platelets of differing size. British Journal of Haematology. 53(3). 503–511. 179 indexed citations

14.

Jakubowski, Joseph A., Craig B. Thompson, R. Vaillancourt, C. R. Valeri, & Daniel Deykin. (1983). Arachidonic acid metabolism by platelets of differing size. British Journal of Haematology. 53(3). 503–511. 41 indexed citations

15.

Vaillancourt, R., et al.. (1980). Platelet arachidonic acid metabolism and platelet function in ten patients with chronic myelogenous leukemia. Blood. 56(4). 728–731. 21 indexed citations

16.

Kolobow, Theodor, et al.. (1978). The Ito “Flow‐Through” Centrifuge A New Device for Long‐Term (24 hours) Plasmapheresis without Platelet Deterioration. Transfusion. 18(3). 312–319. 5 indexed citations

17.

Carvalho, Angelina C. A., R. Vaillancourt, Lot B. Page, et al.. (1978). The Pathogenetic Significance of Intravascular Coagulation in Experimental Acute Renal Failure. The Nephron journals/Nephron journals. 22(4-6). 484–491. 3 indexed citations

18.

Bizios, Rena, Lan K. Wong, R. Vaillancourt, Robert S. Lees, & Angelina C. A. Carvalho. (1977). Platelet Prostaglandin Endoperoxides Formation in Hyperlipidemias. Thrombosis and Haemostasis. 9 indexed citations

19.

Carvalho, Angelina C. A., et al.. (1976). Intravascular coagulation in hyperlipidemia. Thrombosis Research. 8(6). 843–857. 24 indexed citations

20.

Haas, B., P. Taras, J.C. Merdinger, & R. Vaillancourt. (1974). Mean lifetimes of levels in 48V. Nuclear Physics A. 236(2). 405–415. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact